Sensei Biotherapeutics, Inc.
SNSE
$12.63
-$0.37-2.85%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -2,380.13% | 39.29% | 37.02% | 30.89% | 14.11% |
| Total Depreciation and Amortization | -11.76% | -89.73% | -89.76% | -88.72% | -89.73% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 24,463.53% | -61.85% | -43.51% | -48.99% | -59.58% |
| Change in Net Operating Assets | 1,650.64% | 14.40% | -22.22% | -1,850.59% | 39.80% |
| Cash from Operations | -51.30% | 33.29% | 34.44% | -2.02% | 6.85% |
| Capital Expenditure | -- | -- | -- | 85.32% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -629.91% | 166.04% | -86.50% | 22.05% | 23.14% |
| Cash from Investing | -537.16% | 166.04% | -86.50% | 26.78% | 24.63% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 70.62% | 45.41% | 25.49% | -56.22% | -6.03% |
| Issuance of Common Stock | -- | -84.62% | -- | -76.19% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | 70.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 86,934.58% | 42.78% | 25.49% | 6.67% | -2.39% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 122,883.76% | 79.27% | -127.56% | 186.63% | 94.31% |